Navitas Life Sciences

PV Affiliates Risk Assessment

An international pharmaceutical company operating in more than 100 countries had gone through multiple acquisitions, integrations and divestitures over a 12-month period, which impacted pharmacovigilance (PV) oversight of the 44 affiliates who have local drug safety responsibilities, raising the risk of unknown regulatory and legal compliance exposure at a global and local level.

Read more about how Navitas conducted a global PV Affiliates Risk Assessment in order to clarify the current state in each location with respect to resourcing requirements and compliance risk, and how these results led to the development of a new, sustainable Affiliates framework for the worldwide PV organization. 

Please complete form to download Case Study
First Name
Last Name
Business Email
Job Title
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy | EU-US & Swiss-US Privacy Shield Policy

© 2019 Navitas Life Sciences | A TAKE Solutions Enterprise
Privacy Policy | EU-US & Swiss-US Privacy Shield Policy